At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,852 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region
In Brief
An observational study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 4,852 participants across 864 sites in 6 countries.
Detailed Summary
The objective of this observational study is to collect and evaluate data on Health Related Quality of Life (HRQoL) of Spiriva delivered by HandiHaler, using disease specific SGRQ in the national samples of Central \& Central European patients with varying severities of chronic obstructive pulmonary disease (COPD) in the real life setting over the 6 months.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesCroatia, Poland, Romania, Russia, Slovakia, Slovenia
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedNov 2009
Primary CompletionJun 2011
TodayJul 2026
First PostedNov 2, 2009
Enrollment StartOct 1, 2009
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.7 years ago